Description
Recombinant monoclonal antibody to CIP2A. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma HL1925. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
CIP2A
Target Alias Names
Cancerous inhibitor of protein phosphatase 2A, Cancerous inhibitor of PP2A, Protein CIP2A, p90 autoantigen, KIAA1524
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression